TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES |
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: |
Deltex Medical Group plc |
2 Reason for the notification (please tick the appropriate box or boxes): |
||
An acquisition or disposal of voting rights |
No |
|
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
No |
|
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
No |
|
An event changing the breakdown of voting rights |
No |
|
Other (please specify): |
Placing |
Yes |
3. Full name of person(s) subject to the notification obligation: |
Gartmore Investment Limited |
4. Full name of shareholder(s) (if different from 3.): |
See attached schedule |
5. Date of the transaction and date on which the threshold is crossed or reached: |
3rd November 2009 |
6. Date on which issuer notified: |
4th November 2009 |
7. Threshold(s) that is/are crossed or reached: |
5% |
8. Notified details: |
|||||||
A: Voting rights attached to shares |
|||||||
Class/type of
|
Situation previous |
Resulting situation after the triggering transaction |
|||||
Number |
Number |
Number |
Number of voting |
% of voting rights |
|||
Direct |
Direct |
Indirect |
Direct |
Indirect |
|||
GB0059337583 |
n/a |
n/a |
12,401,111 |
|
12,401,111 |
|
9.953% |
|
B: Qualifying Financial Instruments |
||||
Resulting situation after the triggering transaction |
||||
Type of financial |
Expiration |
Exercise/ |
Number of voting |
% of voting |
|
|
|
|
|
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments |
||||||
Resulting situation after the triggering transaction |
||||||
Type of financial |
Exercise |
Expiration |
Exercise/ |
Number of voting |
% of voting rights |
|
|
|
|
|
|
Nominal |
Delta |
|
|
Total (A+B+C) |
|
Number of voting rights |
Percentage of voting rights |
12,401,111 |
9.953% |
9. Chain of controlled undertakings through which the voting rights and/or the |
|
Proxy Voting: |
|
10. Name of the proxy holder: |
|
11. Number of voting rights proxy holder will cease to hold: |
|
12. Date on which proxy holder will cease to hold voting rights: |
|
13. Additional information: |
All figures are based on the Company's issued share capital of 124,598,597 as provided by Exshare E mail contact RDU@Gartmore.com |
14. Contact name: |
RDU |
15. Contact telephone number: |
0207 782 2324 |
Report S793 Current Holdings By Instrument Type 04 NOV 2009 11:43
Page 1 of 1
Stock Line: 3103865 DELTEX MEDICAL GRP ORD GBP0.01 Issued Share Capital: 124,598,597
Share Description Fund Managing Co. |
Shares Held |
% of Issues Share Capital |
UK Registered Owner |
Beneficial Owner |
Equities DELTEX MEDICAL GRP ORD GBP0.01 Gartmore Fund Managers Limited
Gartmore Investment Limited |
6,172,831 6,228,280 |
4.954% 4.999% |
HSBC GLOBAL CUSTODY NOMINEE UK LIMITED VIDACOS NOMINEES LTD A/C 2303 |
GARTMORE FUND MANAGERS LTD A/C GARTMORE UK & IRISH SMALLER COMPANIES THE ALPHAGEN VOLANTIS FUND LIMITED |
|
12,401,111 |
9.953% |
|
|
|
|
|
|
|
|
|
|
|
|
|
12,401,111 |
9.953% |
|
|
End of Report